Tokyo, April 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061078) titled 'IMPACT OF DISEASEMODIFYING ANTIRHEUMATIC DRUGS AND NUTRITIONAL INTERVENTIONS ALONE AND IN COMBINATION A SINGLE-BLINDED STUDY' on April 1.
Study Type:
Interventional
Study Design:
Basic Design - n-of-1
Randomization - Randomized
Blinding - Single blind -participants are blinded
Control - Uncontrolled
Primary Sponsor:
Institute - DEPARTMENT OF HUMAN NUTRITION AND DIETETICS
BACHA KHAN UNIVERSITY CHARSADDA
Condition:
Condition - nil
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - 1. To contrast the impact of DMARDs, nutritional treatment, and their combination in reducing the disease activity in RA patients as measured by DAS28 scores at the end of 9 months.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - DMARDs, nutritional treatment, and their combination
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Patients diagnosed within previous 1 year
Key exclusion criteria - Other diseases, obesity etc
Target Size - 200
Recruitment Status:
Recruitment status - Terminated
Date of protocol fixation - 2025 Year 01 Month 01 Day
Date of IRB - 2025 Year 01 Month 01 Day
Anticipated trial start date - 2025 Year 03 Month 10 Day
Last follow-up date - 2026 Year 04 Month 01 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069889
Disclaimer: Curated by HT Syndication.
